ARCHIVES

Cediranib Demonstates Control In Alveolar Soft Part Sarcoma

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

NCI, Advisors Concur On Need For New Mechanism To Include Cancer Control, Minority Center Needs

September 21, 1984

DCT Board Okays Recompetitions

June 21, 1985

Second-Generation CML Drugs Show Promise For Frontline

December 26, 2008

NCAB Committee Agrees On Seven Characteristics For Comprehensive Centers, Asks For New Division

May 12, 1989

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001

NCI Plans Program To Help Academics With Initial Stages of Drug Discovery.

November 30, 2007